SCHEMBL8049652

SCHEMBL8049652

Cc1ccc(N)c(C)c1C(O[SiH2]C(C)(C)C)(c1ccccc1)c1ccccc1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1315596 0.76 MAPK1 (0.44) MAPK1
SCHEMBL30913766 0.73 MAPT (0.39) MAPK1
SCHEMBL30913780 0.70 MAPK1 (0.42) MAPK1
SCHEMBL15967486 0.70 LPL (0.31)
SCHEMBL5454232 0.68 CYP3A4 (0.42) MAPK1
SCHEMBL3598539 0.67 KDM4E (0.34) MAPK1
SCHEMBL7234998 0.66 TDP1 (0.39) MAPK1
SCHEMBL3598201 0.66 ALOX5AP (0.33) MAPK1
SCHEMBL23910519 0.65 MAPK1 (0.44) MAPK1
SCHEMBL1179212 0.65 CA2 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6083961-A FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES SUCH AS ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE, SHOCK, PAIN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-04 US disclosed